Response to (K)RASG12C and EGFR Inhibition in a Patient With NRASG12C-Mutated Rectal Cancer

JCO Precis Oncol. 2023 May:7:e2200666. doi: 10.1200/PO.22.00666.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ErbB Receptors / genetics
  • GTP Phosphohydrolases / genetics
  • Humans
  • Membrane Proteins
  • Mutation
  • Rectal Neoplasms* / drug therapy
  • Rectal Neoplasms* / genetics

Substances

  • ErbB Receptors
  • EGFR protein, human
  • NRAS protein, human
  • Membrane Proteins
  • GTP Phosphohydrolases